nanospyinc.comAbout company
NanoSpy, Inc. was founded in 2017 to establish the new state-of-the-art in rapid pathogen detection. Using proprietary and patent-pending technologies, we leverage our expertise in biomedical engineering, microbiology, nanomaterials, and mechanical engineering to dramatically simplify the detection process with a new paradigm in biosensor platforms. Sensitivity, specificity, and speed now are combined in one convenient test that delivers results fast! In 20 minutes, NanoSpy biosensors can detect a single targeted pathogen at 5 CFU/mL or less from common buffer samples taken right at the point of detection. No time-consuming enrichment process. No environmentally hazardous reagents. No laboratory requirements. Translation: No time wasted. No decisions delayed.
